Troglitazone stimulates IGF-binding protein-1 by a PPARγ-independent mechanism

作者: Agneta Hilding , Kerstin Hall , Josefin Skogsberg , Ewa Ehrenborg , Moira S Lewitt

DOI: 10.1016/S0006-291X(03)00403-0

关键词: HepatocyteTroglitazoneThiazolidinedioneRosiglitazonePeroxisome proliferator-activated receptorParacrine signallingInsulinEndocrinologyInternal medicineGlucose homeostasisChemistry

摘要: IGFBP-1 modulates IGF availability for glucose homeostasis and it may also play a paracrine role in hepatocyte survival. is inhibited transcriptionally by insulin regulated number of pathways that influence hepatic sensitivity. The effect the thiazolidinedione troglitazone on production was studied HepG2 human hepatoma cells, which were found to express PPAR alpha, gamma, PXR. Troglitazone stimulated mRNA expression 2-fold within 3h exposure (P<0.001) secretion up 3-fold over narrow dose range 24h (P<0.001). This mimicked PXR ligands clotrimazole phenobarbital, but not Wy14,643 or rosiglitazone, are alpha -gamma, respectively. We conclude cells independent involve

参考文章(46)
Nico Landes, Paul Pfluger, Dirk Kluth, Marc Birringer, Ralph Rühl, Gaby-Fleur Böl, Hansruedi Glatt, Regina Brigelius-Flohé, Vitamin E activates gene expression via the pregnane X receptor. Biochemical Pharmacology. ,vol. 65, pp. 269- 273 ,(2003) , 10.1016/S0006-2952(02)01520-4
Moira S. Lewitt, Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase. Biochemical and Biophysical Research Communications. ,vol. 282, pp. 1126- 1131 ,(2001) , 10.1006/BBRC.2001.4702
Helen Simpson, Richard Savine, Peter Sönksen, Bengt-Åke Bengtsson, Lena Carlsson, Jens Sandahl Christiansen, David Clemmons, Pinchus Cohen. Raymond Hintz, Ken Ho, Primus Mullis, Iain Robinson, Christian Strasburger, Toshiaka Tanaka, Michael Thorner, Growth hormone replacement therapy for adults: into the new millennium. Growth Hormone & Igf Research. ,vol. 12, pp. 1- 33 ,(2002) , 10.1054/GHIR.2001.0263
Agneta Hilding, Christer Möller, Kerstin E Hall, Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA. Growth Hormone & Igf Research. ,vol. 12, pp. 60- 68 ,(2002) , 10.1054/GHIR.2001.0262
Junichi Sakamoto, Hiroyuki Kimura, Shinji Moriyama, Hiroyuki Odaka, Yu Momose, Yasuo Sugiyama, Hidekazu Sawada, Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone Biochemical and Biophysical Research Communications. ,vol. 278, pp. 704- 711 ,(2000) , 10.1006/BBRC.2000.3868
L. Wu, E. Eftekharpour, G. F. Davies, W. J. Roesler, B. H. J. Juurlink, Troglitazone selectively inhibits glyoxalase I gene expression. Diabetologia. ,vol. 44, pp. 2004- 2012 ,(2001) , 10.1007/S001250100004
V. Clavey, C. Copin, M.C. Mariotte, E. Baugé, G. Chinetti, J. Fruchart, J.C. Fruchart, J. Dallongeville, B. Staels, Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells. Cellular Physiology and Biochemistry. ,vol. 9, pp. 139- 149 ,(1999) , 10.1159/000016311
Alison J Butt, Sue M Firth, Robert C Baxter, The IGF axis and programmed cell death. Immunology and Cell Biology. ,vol. 77, pp. 256- 262 ,(1999) , 10.1046/J.1440-1711.1999.00822.X
Jean-Marc Pascussi, Youssef Jounaidi, Lionel Drocourt, Jacques Domergue, Charles Balabaud, Patrick Maurel, Marie-Josée Vilarem, Evidence for the Presence of a Functional Pregnane X Receptor Response Element in the CYP3A7 Promoter Gene Biochemical and Biophysical Research Communications. ,vol. 260, pp. 377- 381 ,(1999) , 10.1006/BBRC.1999.0745